This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
Steve,
I think tarhoosier has shown just the right attitude for you in this situation. One small note, a sizeable number of the patients in SWOG 8794 did have various levels of PSA remaining after surgery. There are further analyses of that study based on those levels.
Two large randomized trials (European Organization for Research and Treatment of Cancer [EORTC] trial 229111 and Southwest Oncology Group [SWOG] trial 8794) have now reported on the beneficial outcome of adjuvant radiotherapy in patients with pathological risk factors after prostatectomy.
Visit: